Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation-Reference-Cited by-同舟云学术

Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation

Published:2016-02-25 Issue:3 Volume:22 Page:287-297
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Rowe Ian A.¹²³,Tully Damien C.⁴,Armstrong Matthew J.²³,Parker Richard²³,Guo Kathy²,Barton Darren²⁵,Morse Gene D.⁶,Venuto Charles S.⁷,Ogilvie Colin B.⁴,Hedegaard Ditte L.¹,McKelvy Jeffrey F.⁸,Wong-Staal Flossie⁸,Allen Todd M.⁴,Balfe Peter¹,McKeating Jane A.¹²,Mutimer David J.²³

Affiliation:

1. Viral Hepatitis Laboratory, Centre for Human Virology

2. National Institute for Health Research Birmingham Liver Biomedical Research Unit

3. Liver and Hepatobiliary Unit, Queen Elizabeth Hospital Birmingham; Birmingham UK

4. Ragon Institute of MGH, MIT and Harvard; Cambridge MA

5. Cancer Research UK Clinical Trials Unit; University of Birmingham; Birmingham UK

6. School of Pharmacy and Pharmaceutical Sciences, and New York State Center of Excellence in Bioinformatics and Life Sciences; University at Buffalo, State University of New York; Buffalo NY

7. Center for Human Experimental Therapeutics; University of Rochester School of Medicine; Rochester NY

8. iTherX Pharma Inc.; San Diego CA

Funder

Medical Research Council Programme

National Institutes of Health-National Center for Research Resources

National Institute of Allergy and Infectious Disease

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference40 articles.

1. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR);Adam;J Hepatol,2012